Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells

RM Touyz, EL Schiffrin - Pharmacological reviews, 2000 - ASPET
Until recently, the signaling events elicited in vascular smooth muscle cells by angiotensin II
(Ang II) were considered to be rapid, short-lived, and divided into separate linear pathways …

Regulation of blood pressure and salt homeostasis by endothelin

DE Kohan, NF Rossi, EW Inscho… - Physiological …, 2011 - journals.physiology.org
Endothelin (ET) peptides and their receptors are intimately involved in the physiological
control of systemic blood pressure and body Na homeostasis, exerting these effects through …

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

TF Luscher, M Barton - Circulation, 2000 - Am Heart Assoc
The 21-amino acid peptide endothelin-1 (ET-1) is the predominant isoform of the endothelin
peptide family, which includes ET-2, ET-3, and ET-4. It exerts various biological effects …

Role of endothelin-1 in hypertension and vascular disease

EL Schiffrin - American journal of hypertension, 2001 - academic.oup.com
Abstract Endothelin-1 (ET-1) is a powerful vasoconstrictor peptide and regulator of blood
flow that plays an important role in blood pressure (BP) elevation in some models of …

Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

B Hocher, C Thöne-Reineke… - The Journal of …, 1997 - Am Soc Clin Investig
The human endothelin-1 (ET-1) gene under the control of its natural promoter was
transferred into the germline of mice. The transgene was expressed predominantly in the …

[HTML][HTML] Endothelin-1 in health and disease

KMRM Banecki, KA Dora - International journal of molecular sciences, 2023 - mdpi.com
Discovered almost 40 years ago, the potent vasoconstrictor peptide endothelin-1 (ET-1) has
a wide range of roles both physiologically and pathologically. In recent years, there has …

Endothelin: 30 years from discovery to therapy

M Barton, M Yanagisawa - Hypertension, 2019 - Am Heart Assoc
Discovered in 1987 as a potent endothelial cell–derived vasoconstrictor peptide, endothelin-
1 (ET-1), the predominant member of the endothelin peptide family, is now recognized as a …

Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling

Q Pu, MF Neves, A Virdis, RM Touyz, EL Schiffrin - Hypertension, 2003 - Am Heart Assoc
Endothelin A (ETA) receptor blockade has prevented vascular remodeling in aldosterone
and salt-induced hypertension. To evaluate effects of the ETA receptor antagonist, BMS …

Ontogenetic aspects of hypertension development: analysis in the rat

J Zicha, J Kunes - Physiological Reviews, 1999 - journals.physiology.org
In this review, we attempt to outline the age-dependent interactions of principal systems
controlling the structure and function of the cardiovascular system in immature rats …

Angiotensin II Increases Tissue Endothelin and Induces Vascular Hypertrophy: Reversal by ETA-Receptor Antagonist

P Moreau, LV d'Uscio, S Shaw, H Takase, M Barton… - Circulation, 1997 - Am Heart Assoc
Background In vitro studies on vascular smooth muscle cells suggest that endothelin has a
stimulating effect on cellular proliferation. This study was designed to determine the …